Location History:
- Kanagawa, JP (2015)
- Yokohama, JP (2009 - 2020)
Company Filing History:
Years Active: 2009-2020
Title: Haruhiko Koseki: Innovator in Immunotherapy
Introduction
Haruhiko Koseki is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of immunotherapy, particularly in the development of innovative treatments using NKT cells. With a total of 4 patents, Koseki's work is at the forefront of cancer and autoimmune disease research.
Latest Patents
Koseki's latest patents include groundbreaking inventions such as immunotherapy using allo-NKT cells and cells for immunotherapy where the alpha chain of the T-cell receptor (TCR) gene has been rearranged to uniform Vα-Jα. His inventions provide agents for immunocyte therapy, comprising NKT cells obtained by differentiating in vitro a cell with a rearranged TCR gene. These innovations are aimed at treating cancer, infections, allergic diseases, and autoimmune diseases.
Career Highlights
Throughout his career, Koseki has worked with notable organizations, including RIKEN Corporation and the Kazusa DNA Research Institute Foundation. His research has focused on generating mature NKT cells from reprogrammed somatic cells, contributing to advancements in immune cell therapy.
Collaborations
Koseki has collaborated with esteemed colleagues such as Hiroshi Watarai and Masaru Taniguchi. Their joint efforts have furthered the understanding and application of NKT cell therapies.
Conclusion
Haruhiko Koseki's innovative work in immunotherapy exemplifies the potential of NKT cells in treating various diseases. His contributions continue to influence the field and inspire future research in immunological therapies.